✦ LIBER ✦

642: 11C-MET-PET for monitoring of early treatment response in multiple myeloma

✍ Scribed by Lückerath, K.; Lapa, C.; Samnick, S.; Einsele, H.; Knop, S.; Buck, A.K.

Book ID: 125800177
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 67 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(14)50563-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

11C-Acetate as a new biomarker for PET/C

11C-Acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment

✍ Lin, Chieh; Ho, Chi-Lai; Ng, Shu-Hang; Wang, Po-Nan; Huang, Yenlin; Lin, Yu-Chun 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 351 KB

[18F]FLT PET for Non-Invasive Monitoring

[18F]FLT PET for Non-Invasive Monitoring of Early Response to Gene Therapy in Experimental Gliomas

✍ Maria A. Rueger; Mitra Ameli; Hongfeng Li; Alexandra Winkeler; Benedikt Rueckrie 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 479 KB

Diffusion-weighted MRI compared to FDG P

Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma

✍ Hagtvedt, T.; Seierstad, T.; Lund, K. V.; Londalen, A. M.; Bogsrud, T. V.; Smith 📂 Article 📅 2015 🏛 Royal Society of Medicine Press 🌐 English ⚖ 217 KB

Assessing response rates in clinical tri

Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide

✍ Prince, H M; Schenkel, B; Mileshkin, L 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 83 KB

1165 CLINICAL UTILITY OF THE ARCHITECT H

1165 CLINICAL UTILITY OF THE ARCHITECT HCV AG ASSAY FOR EARLY TREATMENT RESPONSE MONITORING IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION

✍ Vermehren, J.; Süsser, S.; Berger, A.; Perner, D.; Peiffer, K.H.; Zeuzem, S.; Sa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Pyridinium cross-links in multiple myelo

Pyridinium cross-links in multiple myeloma: Correlation with clinical parameters and use for monitoring of intravenous clodronate therapy—A pilot study of the German Myeloma Treatment Group (GMTG)

✍ D. Peest; H. Deicher; W. Fett; P. Harms; H.J. Braun; M. Planker; U. Kindler; C. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 591 KB